3,5-Dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane
(3R,5R)-3,5-dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-heptane may have anti-adipogenic activity.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
J Nat Med.2022, 76(1):59-67.
J-STAGE2015, 249-255
Molecules.2017, 22(6)
Int J Mol Sci.2020, 21(19):7209.
Proc Natl Acad Sci USA.2016, 113(30):E4407-1
Toxicol In Vitro.2022, 81:105346.
Phytother Res.2015, 29(7):1088-96
Natural Product Sciences2023, 29(4):276-280.
J Vet Sci.2020, 21(3):e39.
Evid Based Complement Alternat Med.2017, 2017:7383104
Related and Featured Products
Journal of Proteome Research, 2018:acs.jproteome.8b00028.
Multiplatform Metabolomics Investigation of Anti-Adipogenic Effects on 3T3-L1 Adipocytes by a Potent Diarylheptanoid.[Reference:
WebLink]
Obesity is fast becoming a serious health problem worldwide. Of the many possible anti-obesity strategies, one interesting approach focuses on blocking adipocyte differentiation and lipid accumulation to counteract the rise in fat storage. However, there is currently no drug available for the treatment of obesity that works by inhibiting adipocyte differentiation.
CONCLUSIONS:
Here we use a broad-based metabolomics approach to interrogate and better understand metabolic changes that occur during adipocyte differentiation. In particular, we focus on changes induced by the anti-adipogenic diarylheptanoid, which was isolated from a traditional Chinese medicine Dioscorea zingiberensis and identified as (3R,5R)-3,5-Dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane (1). Targeted aqueous metabolic profiling indicated that a total of 14 metabolites involved in the TCA cycle, glycolysis, amino acid metabolism, and purine catabolism participate in regulating energy metabolism, lipogenesis, and lipolysis in adipocyte differentiation and can be modulated by diarylheptanoid 1. As indicated by lipidomics analysis, diarylheptanoid 1 restored the quantity and degree of unsaturation of long chain free fatty acids, and restored the levels of 171 lipids mainly from 10 lipid species in adipocytes. In addition, carbohydrate metabolism in diarylheptanoid 1 treated adipocytes further demonstrated the delayed differentiation process by flux analysis.
CONCLUSIONS:
Our results provide valuable information for further understanding the metabolic adjustment in adipocytes subjected to diarylheptanoid 1 treatment. Moreover, this study offers new insight into developing anti-adipogenic leading compounds based on metabolomics.
